|
2021
|
Invention
|
Uses of ornithine phenylacetate for treating hyperammonemia. Embodiments of the present disclosur... |
|
2020
|
Invention
|
Dosages and uses of ornithine phenylacetate for treating hyperammonemia. Embodiments of the prese... |
|
|
Invention
|
Methods of assessing and treating hepatic encephalopathy. The present disclosure relates to metho... |
|
2018
|
Invention
|
Processes of making l-ornithine phenylacetate. Embodiments of the present disclosure are related ... |
|
|
Invention
|
Macrocyclic ghrelin receptor modulators and methods of using the same. The present invention prov... |
|
2016
|
Invention
|
Formulations of l-ornithine phenylacetate. Some embodiments of the present application are direct... |
|
|
Invention
|
Formulation of l-ornithine phenylacetate. Some embodiments of the present application are directe... |
|
|
Invention
|
Macrocyclic modulators of the ghrelin receptor.
The present invention provides novel conformatio... |
|
|
Invention
|
Treatment and prevention of neuronal cell loss using l-ornithine in combination with at least one... |
|
|
Invention
|
Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phe... |
|
|
G/S
|
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related condi... |
|
2015
|
Invention
|
Intermediates for macrocyclic compounds. The present invention is directed to novel macrocyclic c... |
|
|
Invention
|
Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery. A library... |
|
2014
|
Invention
|
Macrocyclic modulators of the ghrelin receptor. The present invention provides novel conformation... |
|
2011
|
Invention
|
Methods of making l-ornithine phenyl acetate. Disclosed herein are processes for making L-ornithi... |
|
|
Invention
|
Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor. The present inv... |
|
|
Invention
|
Processes for intermediates for macrocyclic compounds. The present invention is directed to novel... |
|
|
Invention
|
Spatially-defined macrocyclic compounds useful for drug discovery. Novel spatially-defined macroc... |
|
2010
|
Invention
|
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same. The ... |
|
|
Invention
|
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same.
The... |
|
|
Invention
|
Phenylacetate and/or phenylbutyrate (not ornithine) for reducing portal blood pressure. The prese... |
|
|
Invention
|
Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome. Adsorbent car... |
|
|
Invention
|
Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetat... |
|
|
Invention
|
Use of adsorbent carbon microspheres for the treatment of pruritus. Disclosed herein are methods ... |
|
|
Invention
|
L-ornithine phenyl acetate and methods of making thereof. Disclosed herein are crystalline forms ... |
|
|
Invention
|
L-ornithine phenyl acetate and methods of making thereof. Disclosed herein are crystalline founs ... |
|
2009
|
Invention
|
Methods of using macrocyclic modulators of the ghrelin receptor. The present invention provides n... |
|
|
Invention
|
Spatially-defined macrocycles incorporating peptide bond surrogates. Novel spatially-defined macr... |
|
|
Invention
|
Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor. The present invention pro... |
|
2008
|
G/S
|
Discovery research, development and clinical testing in the field of pharmaceutical preparations,... |
|
2007
|
G/S
|
Biotechnology research, development and testing in the field of gene therapy, vaccine delivery, a... |
|
|
Invention
|
Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility dis... |
|
|
G/S
|
Pharmaceuticals for use in the treatment of gastrointestinal conditions and diseases. |
|
2006
|
G/S
|
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, cardio-vascular, gastro... |
